ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: To extend the mouse model to human leukaemia, we first used K562, which is a BCR-ABL positive cell line derived from a CML patient in blast crisis and are resistant to most forms of chemotherapy.